HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Buko Lindner Selected Research

lipopeptidophosphoglycan

5/2009Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Buko Lindner Research Topics

Disease

8Hypersensitivity (Allergy)
08/2012 - 02/2003
4Infections
06/2011 - 05/2004
2Inflammation (Inflammations)
01/2014 - 08/2009
2Septic Shock (Toxic Shock Syndrome)
01/2013 - 05/2004
2Bovine Mastitis
11/2012 - 06/2011
2Asthma (Bronchial Asthma)
08/2012 - 07/2002
2Plague (Bubonic Plague)
06/2010 - 04/2002
2Tuberculosis (Tuberculoses)
10/2008 - 12/2006
1Peanut Hypersensitivity (Peanut Allergy)
11/2015
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2015
1Colitis
03/2014
1Edema (Dropsy)
09/2011
1Mastitis
06/2011
1Immediate Hypersensitivity
03/2010
1Abscess
05/2009
1Amebic Liver Abscess
05/2009
1Neoplasms (Cancer)
06/2007
1Meningococcal Infections
01/2007
1Sepsis (Septicemia)
01/2007
1Meningitis
01/2007
1Vasculitis (Vasculitides)
06/2006
1Crohn Disease (Crohn's Disease)
06/2006
1Granuloma
06/2006
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
06/2006
1Rickettsia Infections
11/2003
1Rupture
11/2003
1Allergic Rhinitis
07/2002

Drug/Important Bio-Agent (IBA)

6AllergensIBA
11/2015 - 07/2002
6LipopolysaccharidesIBA
03/2014 - 04/2002
3Immunoglobulin E (IgE)IBA
11/2015 - 05/2004
3AcidsIBA
11/2012 - 04/2002
2OvalbuminIBA
01/2014 - 08/2012
2GlycolipidsIBA
01/2013 - 02/2003
2EndotoxinsIBA
01/2007 - 05/2004
1Proteins (Proteins, Gene)FDA Link
11/2015
1hypoxanthine arabinoside (ara-H)IBA
11/2015
1DefensinsIBA
11/2015
1LipidsIBA
01/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2014
1Conjugated Linoleic AcidsIBA
01/2014
1Lipid AIBA
01/2013
1Teichoic AcidsIBA
08/2012
1Cysteine Proteases (Cysteine Protease)IBA
03/2012
1Biomarkers (Surrogate Marker)IBA
03/2012
1actinidainIBA
03/2012
1CytokinesIBA
12/2011
1Toll-Like Receptor 2IBA
12/2011
1EicosanoidsIBA
09/2011
1Platelet Activating FactorIBA
09/2011
1O Antigens (O Antigen)IBA
06/2011
1Peptide Hydrolases (Proteases)FDA Link
06/2010
1PlasminogenIBA
06/2010
1Virulence Factors (Pathogenicity Factors)IBA
06/2010
1Cysteine Proteinase InhibitorsIBA
03/2010
1Antimicrobial Cationic PeptidesIBA
09/2009
1Tryptases (Tryptase)IBA
08/2009
1CathelicidinsIBA
08/2009
1lipopeptidophosphoglycanIBA
05/2009
1alpha-galactosylceramideIBA
05/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008
1lipoarabinomannan (LAM)IBA
10/2008
1lipomannanIBA
10/2008
1phosphatidylinositol mannosideIBA
10/2008
1Interleukin-12 Subunit p40IBA
10/2008
1GlycosyltransferasesIBA
10/2008
1Polysaccharides (Glycans)IBA
06/2007
1Toll-Like Receptor 4IBA
01/2007
1Immunologic Factors (Immunomodulators)IBA
12/2006
1AutoantigensIBA
06/2006
1Myeloblastin (Proteinase 3)IBA
06/2006
1AutoantibodiesIBA
06/2006
1Fatty Acids (Saturated Fatty Acids)IBA
05/2004
1Glycoproteins (Glycoprotein)IBA
05/2004
1CarbohydratesIBA
05/2004
1Protein Isoforms (Isoforms)IBA
05/2004
1OligosaccharidesIBA
11/2003
1AntigensIBA
11/2003
1Ether (Diethyl Ether)IBA
02/2003
1Galactose (Galactopyranose)FDA LinkGeneric
04/2002